The Latest Breaking News from Pfizer

The government now needs to place an order and set a delivery schedule, given the limited supply

A video has emerged of a Food and Drug Administration executive suggesting there are plans for annual COVID-19 vaccines to be implemented in the United States.

As the omicron wave peaked in the U.S. last month, the first-line treatment for high-risk patients with early COVID-19 dangled out of reach for most. Only a trickle of the new Paxlovid pill from Pfizer Inc. was reaching hospitals and pharmacies.

Biotech stocks are down and out right now. But sentiment can turn on a dime. Here are trends to watch in the biotech sector in 2022.

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 25 strange trades.

Pfizer/BioNTech jab to be offered to younger children as experts decide benefits outweigh risks

This blog is now closed.

Review finds those who have received two doses of Pfizer/BioNTech, AstraZeneca or Moderna vaccine, or one dose of single-shot J&J vaccine, half as likely to develop long Covid symptoms

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may…